We describe the case of a 64 years-old woman admitted to the Emergency Department of the ASST-Spedali Civili of Brescia with fever and gastrointestinal symptoms 10 days after the first dose of ChAdOx1 nCov-19 vaccine. Laboratory investigations showed severe thrombocytopenia and high D-dimer, while an abdominal CT scan reported a partially occluding thrombosis of the superior mesenteric artery. Following treatment with fondaparinux, immunoglobulins and high dosage steroid therapy, we observed a rapid improvement of patient’s conditions. An ELISA assay showed the presence of antibodies against heparin PF4-complex. Subsequent abdominal CT-scan showed the superior mesenteric artery thrombosis resolution, and the patient was finally discharged a...
Vaccine-induced immune thrombotic thrombocytopenia (VITT) is a novel entity that emerged in March 20...
After the vaccination campaign initiation in Europe and the UK, reports of rare cases of atypical th...
Vaccines for COVID-19were developed with unprecedented speedand since January 2021, the AstraZeneca/...
OBJECTIVE: Vaccine-induced immune thrombocytopenia (VITT) is a new syndrome occurring primarily in h...
Abstract The ChAdOx1 nCoV-19 adenoviral vector vaccine to prevent contracting Covid-19 caused by inf...
Abstract Vaccination with ChAdOx1 nCov‐19 can result in vaccine‐induced immune thrombotic thrombocyt...
Abstract Background Vaccine-induced immune thrombotic thrombocytopenia is emerging as one of the mos...
The ChAdOx1 nCoV-19 adenoviral vector-based vaccine was the first to be approved against COVID-19 in...
COVID-19 has significantly affected public health, social life, and economies worldwide. The only ef...
Vaccination with ChAdOx1 nCoV-19 can result in vaccine-induced immune thrombotic thrombocytopenia (V...
Coronavirus disease 2019 (COVID-19) vaccines were developed a few months after the emergence of the ...
The ChAdOx1 nCoV-19 vaccine has been associated with increased risk of thrombosis. Understanding of ...
We report findings in five patients who presented with venous thrombosis and thrombocytopenia 7 to 1...
The coronavirus disease (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus ...
Objective: We describe a severe case of vaccine-induced immune thrombotic thrombocytopenia (VITT) af...
Vaccine-induced immune thrombotic thrombocytopenia (VITT) is a novel entity that emerged in March 20...
After the vaccination campaign initiation in Europe and the UK, reports of rare cases of atypical th...
Vaccines for COVID-19were developed with unprecedented speedand since January 2021, the AstraZeneca/...
OBJECTIVE: Vaccine-induced immune thrombocytopenia (VITT) is a new syndrome occurring primarily in h...
Abstract The ChAdOx1 nCoV-19 adenoviral vector vaccine to prevent contracting Covid-19 caused by inf...
Abstract Vaccination with ChAdOx1 nCov‐19 can result in vaccine‐induced immune thrombotic thrombocyt...
Abstract Background Vaccine-induced immune thrombotic thrombocytopenia is emerging as one of the mos...
The ChAdOx1 nCoV-19 adenoviral vector-based vaccine was the first to be approved against COVID-19 in...
COVID-19 has significantly affected public health, social life, and economies worldwide. The only ef...
Vaccination with ChAdOx1 nCoV-19 can result in vaccine-induced immune thrombotic thrombocytopenia (V...
Coronavirus disease 2019 (COVID-19) vaccines were developed a few months after the emergence of the ...
The ChAdOx1 nCoV-19 vaccine has been associated with increased risk of thrombosis. Understanding of ...
We report findings in five patients who presented with venous thrombosis and thrombocytopenia 7 to 1...
The coronavirus disease (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus ...
Objective: We describe a severe case of vaccine-induced immune thrombotic thrombocytopenia (VITT) af...
Vaccine-induced immune thrombotic thrombocytopenia (VITT) is a novel entity that emerged in March 20...
After the vaccination campaign initiation in Europe and the UK, reports of rare cases of atypical th...
Vaccines for COVID-19were developed with unprecedented speedand since January 2021, the AstraZeneca/...